Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report)’s share price shot up 5.1% on Wednesday . The stock traded as high as $4.73 and last traded at $4.55. 55,136 shares were traded during mid-day trading, a decline of 59% from the average session volume of 136,076 shares. The stock had previously closed at $4.33.
Elevai Labs Stock Down 3.2 %
The company has a market cap of $2.47 million, a PE ratio of -0.07 and a beta of -2.95. The stock has a 50-day moving average of $8.41 and a 200-day moving average of $49.98. The company has a quick ratio of 3.40, a current ratio of 3.86 and a debt-to-equity ratio of 0.06.
Elevai Labs Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Further Reading
- Five stocks we like better than Elevai Labs
- How to Calculate Return on Investment (ROI)
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What Are Trending Stocks? Trending Stocks Explained
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Dividend Capture Strategy: What You Need to Know
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
